InvestorsHub Logo
Followers 83
Posts 36200
Boards Moderated 0
Alias Born 03/09/2010

Re: SkyLimit2022 post# 534968

Friday, 11/18/2022 11:44:57 AM

Friday, November 18, 2022 11:44:57 AM

Post# of 698718
too bad that I have the actual truth from the SAP

here is what they said:

A crossover option was included in the Trial design on demand of patients and investigators, and was
necessary to enable recruitment and retention of patients when the Trial began 13 years ago in
2007.

whats missing FDA LOL LOL, this could cause real problems with the FDA

THEY HATE ME CAUSE THEY AINT ME

NAILED IT ON EVERY STOCK

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News